171 related articles for article (PubMed ID: 28665983)
1. Different levels of let-7d expression modulate response of FaDu cells to irradiation and chemotherapeutics.
Lamperska KM; Kolenda T; Teresiak A; Kowalik A; Kruszyna-Mochalska M; Jackowiak W; Bliźniak R; Przybyła W; Kapałczyńska M; Kozlowski P
PLoS One; 2017; 12(6):e0180265. PubMed ID: 28665983
[TBL] [Abstract][Full Text] [Related]
2. Low let-7d and high miR-205 expression levels positively influence HNSCC patient outcome.
Kolenda T; Guglas K; Teresiak A; Bliźniak R; Lamperska K
J Biomed Sci; 2019 Feb; 26(1):17. PubMed ID: 30755200
[TBL] [Abstract][Full Text] [Related]
3. Let-7d functions as novel regulator of epithelial-mesenchymal transition and chemoresistant property in oral cancer.
Chang CJ; Hsu CC; Chang CH; Tsai LL; Chang YC; Lu SW; Yu CH; Huang HS; Wang JJ; Tsai CH; Chou MY; Yu CC; Hu FW
Oncol Rep; 2011 Oct; 26(4):1003-10. PubMed ID: 21725603
[TBL] [Abstract][Full Text] [Related]
4. Transcriptomic analyses of the radiation response in head and neck squamous cell carcinoma subclones with different radiation sensitivity: time-course gene expression profiles and gene association networks.
Michna A; Schötz U; Selmansberger M; Zitzelsberger H; Lauber K; Unger K; Hess J
Radiat Oncol; 2016 Jul; 11():94. PubMed ID: 27455841
[TBL] [Abstract][Full Text] [Related]
5. Unpredictable changes of selected miRNA in expression profile of HNSCC.
Lamperska KM; Kozlowski P; Kolenda T; Teresiak A; Blizniak R; Przybyla W; Masternak MM; Golusinski P; Golusinski W
Cancer Biomark; 2016; 16(1):55-64. PubMed ID: 26484611
[TBL] [Abstract][Full Text] [Related]
6. Let-7 expression is a significant determinant of response to chemotherapy through the regulation of IL-6/STAT3 pathway in esophageal squamous cell carcinoma.
Sugimura K; Miyata H; Tanaka K; Hamano R; Takahashi T; Kurokawa Y; Yamasaki M; Nakajima K; Takiguchi S; Mori M; Doki Y
Clin Cancer Res; 2012 Sep; 18(18):5144-53. PubMed ID: 22847808
[TBL] [Abstract][Full Text] [Related]
7. let-7d-3p is associated with apoptosis and response to neoadjuvant chemotherapy in ovarian cancer.
García-Vázquez R; Gallardo Rincón D; Ruiz-García E; Meneses García A; Hernández De La Cruz ON; Astudillo-De La Vega H; Isla-Ortiz D; Marchat LA; Salinas-Vera YM; Carlos-Reyes Á; López-González S; Ramos-Payan R; López-Camarillo C
Oncol Rep; 2018 Jun; 39(6):3086-3094. PubMed ID: 29658612
[TBL] [Abstract][Full Text] [Related]
8. Livin enhances chemoresistance in head and neck squamous cell carcinoma.
Yoon TM; Kim SA; Lee DH; Lee JK; Park YL; Lee KH; Chung IJ; Joo YE; Lim SC
Oncol Rep; 2017 Jun; 37(6):3667-3673. PubMed ID: 28440463
[TBL] [Abstract][Full Text] [Related]
9. Tumor suppressive microRNA-375 regulates oncogene AEG-1/MTDH in head and neck squamous cell carcinoma (HNSCC).
Nohata N; Hanazawa T; Kikkawa N; Mutallip M; Sakurai D; Fujimura L; Kawakami K; Chiyomaru T; Yoshino H; Enokida H; Nakagawa M; Okamoto Y; Seki N
J Hum Genet; 2011 Aug; 56(8):595-601. PubMed ID: 21753766
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA expression profiles of cancer stem cells in head and neck squamous cell carcinoma.
Yata K; Beder LB; Tamagawa S; Hotomi M; Hirohashi Y; Grenman R; Yamanaka N
Int J Oncol; 2015 Oct; 47(4):1249-56. PubMed ID: 26323893
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA expression profiles of head and neck squamous cell carcinoma with docetaxel-induced multidrug resistance.
Dai Y; Xie CH; Neis JP; Fan CY; Vural E; Spring PM
Head Neck; 2011 Jun; 33(6):786-91. PubMed ID: 21560177
[TBL] [Abstract][Full Text] [Related]
12. Involvement of let-7 microRNA for the therapeutic effects of Rhenium-188-embedded liposomal nanoparticles on orthotopic human head and neck cancer model.
Lin LT; Chang CY; Chang CH; Wang HE; Chiou SH; Liu RS; Lee TW; Lee YJ
Oncotarget; 2016 Oct; 7(40):65782-65796. PubMed ID: 27588466
[TBL] [Abstract][Full Text] [Related]
13. [Construction of let-7d expression vector and its inhibitory effect on HMGA2 and ras expression in human ovarian cancer cells in vitro].
Ye H; Chen J; Huang X; Guo A; Hao P
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Dec; 32(12):1752-7. PubMed ID: 23268403
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of drug transporters' significance for multidrug resistance in head and neck squamous cell carcinoma.
Theile D; Ketabi-Kiyanvash N; Herold-Mende C; Dyckhoff G; Efferth T; Bertholet V; Haefeli WE; Weiss J
Head Neck; 2011 Jul; 33(7):959-68. PubMed ID: 20737486
[TBL] [Abstract][Full Text] [Related]
15. The Expression of Checkpoint and DNA Repair Genes in Head and Neck Cancer as Possible Predictive Factors.
Rusz O; Pál M; Szilágyi É; Rovó L; Varga Z; Tomisa B; Fábián G; Kovács L; Nagy O; Mózes P; Reisz Z; Tiszlavicz L; Deák P; Kahán Z
Pathol Oncol Res; 2017 Apr; 23(2):253-264. PubMed ID: 27411922
[TBL] [Abstract][Full Text] [Related]
16. Signaling via ErbB2 and ErbB3 associates with resistance and epidermal growth factor receptor (EGFR) amplification with sensitivity to EGFR inhibitor gefitinib in head and neck squamous cell carcinoma cells.
Erjala K; Sundvall M; Junttila TT; Zhang N; Savisalo M; Mali P; Kulmala J; Pulkkinen J; Grenman R; Elenius K
Clin Cancer Res; 2006 Jul; 12(13):4103-11. PubMed ID: 16818711
[TBL] [Abstract][Full Text] [Related]
17. Co-targeting of multiple microRNAs on factor-Inhibiting hypoxia-Inducible factor gene for the pathogenesis of head and neck carcinomas.
Kao SY; Tsai MM; Wu CH; Chen JJ; Tseng SH; Lin SC; Chang KW
Head Neck; 2016 Apr; 38(4):522-8. PubMed ID: 25351569
[TBL] [Abstract][Full Text] [Related]
18. Antitumor miR-150-5p and miR-150-3p inhibit cancer cell aggressiveness by targeting SPOCK1 in head and neck squamous cell carcinoma.
Koshizuka K; Hanazawa T; Kikkawa N; Katada K; Okato A; Arai T; Idichi T; Osako Y; Okamoto Y; Seki N
Auris Nasus Larynx; 2018 Aug; 45(4):854-865. PubMed ID: 29233721
[TBL] [Abstract][Full Text] [Related]
19. Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting.
Sok JC; Coppelli FM; Thomas SM; Lango MN; Xi S; Hunt JL; Freilino ML; Graner MW; Wikstrand CJ; Bigner DD; Gooding WE; Furnari FB; Grandis JR
Clin Cancer Res; 2006 Sep; 12(17):5064-73. PubMed ID: 16951222
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA profile in site-specific head and neck squamous cell cancer.
Kalfert D; Pesta M; Kulda V; Topolcan O; Ryska A; Celakovsky P; Laco J; Ludvikova M
Anticancer Res; 2015 Apr; 35(4):2455-63. PubMed ID: 25862914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
